Allecra Seeks US Partnership For Urinary Tract Asset As Regulatory Filings Approach
Following EU And China Deals
The French firm is searching for a US partner with strong foundations in the hospital sector after securing EU and China deals for its complicated urinary tract infection candidate that combines cefepime and enmetazobactam, which is nearing regulatory submission in key markets.
